ロード中...
P16.09 VALUE OF FET-PET EVALUATION IN PATIENTS TREATED WITH AXITINIB
INTRODUCTION: VEGF/VEGFR targeted therapy for recurrent glioblastoma (rGB) normalizes tumour vasculature and restores the blood-brain barrier (BBB), resulting in decreased contrast enhancement and reduced peritumoral oedema. MRI-T2/FLAIR images are useful to document non-contrast-enhancing tumor pro...
保存先:
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4185667/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou174.305 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|